These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients. Hayde N, Solomon S, Caglar E, Ge J, Qama E, Colovai A. Pediatr Transplant; 2021 Mar; 25(2):e13885. PubMed ID: 33131194 [Abstract] [Full Text] [Related]
9. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Freitas MC, Rebellato LM, Ozawa M, Nguyen A, Sasaki N, Everly M, Briley KP, Haisch CE, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI. Transplantation; 2013 May 15; 95(9):1113-9. PubMed ID: 23514959 [Abstract] [Full Text] [Related]
10. Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation. Thammanichanond D, Wiwattanathum P, Mongkolsuk T, Kantachuvesiri S, Worawichawong S, Vallipakorn SA, Kitpoka P. Transplant Proc; 2016 Apr 15; 48(3):756-60. PubMed ID: 27234729 [Abstract] [Full Text] [Related]
11. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, Bachelet T, Lepreux S, Visentin J, Merville P, Fremeaux-Bacchi V, Morelon E, Taupin JL, Dubois V, Thaunat O. J Am Soc Nephrol; 2015 Feb 15; 26(2):457-67. PubMed ID: 25125383 [Abstract] [Full Text] [Related]
12. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation. Farrero Torres M, Pando MJ, Luo C, Luikart H, Valantine H, Khush K. Clin Transplant; 2017 Nov 15; 31(11):. PubMed ID: 28940521 [Abstract] [Full Text] [Related]
14. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation. Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M. Transplantation; 2018 Apr 15; 102(4):688-698. PubMed ID: 29135832 [Abstract] [Full Text] [Related]
15. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study. Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, Magnasco A, Trivelli A, Klersy C, Gurrado A, Ramondetta M, Boghen S, Catenacci L, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Comoli P. Transpl Int; 2019 Jan 15; 32(1):38-48. PubMed ID: 30076765 [Abstract] [Full Text] [Related]
16. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A. J Heart Lung Transplant; 2020 Dec 15; 39(12):1417-1425. PubMed ID: 32981841 [Abstract] [Full Text] [Related]